咽部舌根增厚术治疗吞咽困难:头颈癌治疗后患者的前瞻性病例系列研究
本研究对头颈癌多模式治疗后中重度吞咽困难患者行咽部舌根增厚术(PAD治疗),先用透明质酸临时填充剂,后续行长效脂肪填充。采用悉尼吞咽问卷(SSQ)、高分辨率咽部测压(HRPM)和电视透视吞咽造影(VFSS)评估,统计采用配对检验。结果显示PAD治疗安全并改善吞咽困难症状,但未能解决残留或误吸问题。
要点
- 头颈癌治疗后中重度吞咽困难患者可考虑PAD治疗,但需注意其未能改善残留或误吸。
- SSQ评分从基线均值1069降至透明质酸后均值579(p>0.05),脂肪填充后491(p=0.003,n=4)。
- 部分患者吞咽风险指数和食团停留时间降低、食管上括约肌开放增加,但咽中段收缩压未变。
核心结论
- 新型PAD治疗安全并改善吞咽困难症状。
- 生物力学吞咽变化提示在保守填充量下食团推进更有效,但未能解决残留或误吸指标。
研究设计与样本
- 前瞻性病例系列研究,纳入头颈癌治疗后中重度吞咽困难成人患者。
- PAD治疗先使用透明质酸临时填充剂,随访时行长效脂肪填充。
- 吞咽评估采用悉尼吞咽问卷(SSQ)、高分辨率咽部测压(HRPM)和电视透视吞咽造影(VFSS),统计比较采用配对检验。
- 共6名参与者,均为男性,中位年龄64岁(IQR 56,71)。
主要发现
- 患者在治疗后中位47个月(IQR 8,95)时接受PAD治疗。
- SSQ评分从基线均值1069(95%CI 703,1434)降至透明质酸后均值579(95%CI 76,1081,p>0.05),脂肪填充后491(95%CI 913,789,p=0.003,n=4)。
- 部分个体患者吞咽风险指数和食团停留时间降低,食管上括约肌开放增加,但咽中段收缩压未变。
- VFSS评估的误吸、残留和严重程度指标未变。
关键数值与推荐
- SSQ评分基线均值1069(95%CI 703,1434),透明质酸后均值579(95%CI 76,1081,p>0.05),脂肪填充后491(95%CI 913,789,p=0.003,n=4)。
- PAD治疗在头颈癌治疗后中位47个月(IQR 8,95)进行,参与者中位年龄64岁(IQR 56,71)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 样本量小(6名参与者)。
- 脂肪填充后SSQ分析仅n=4。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Dysphagia post head and neck cancer (HNC) multimodality treatment is attributed to reduced pharyngeal strength. We hypothesized that pharyngeal tongue base augmentation for dysphagia (PAD therapy) would increase pharyngeal pressures during swallowing thereby improving swallow symptoms. METHODS: Adults with moderate-severe dysphagia post-HNC treatment had PAD therapy using a temporary filler (hyaluronic acid [HA]), with follow-up long-lasting lipofilling. Swallowing preprocedure and postprocedure was assessed with the Sydney Swallow Questionnaire (SSQ), High-Resolution Pharyngeal Manometry (HRPM), and Videofluoroscopic Swallowing Study (VFSS). Statistical comparison utilized paired tests. RESULTS: Six participants (all male; median age 64 years [IQR 56, 71]) underwent PAD therapy at a median of 47 [IQR 8, 95] months post-treatment. SSQ scores reduced from baseline (mean 1069 [95%CI 703, 1434]) to post-HA (mean 579 [76, 1081], p > 0.05), and post-lipofilling (491 [95%CI 913, 789], p = 0.003, n = 4). Individual participants demonstrated reduced Swallow Risk Index, Bolus Presence Time, and increased Upper Esophageal Sphincter opening, but mesopharyngeal contractile pressures were unchanged. VFSS measures of aspiration, residue, and severity were unchanged. CONCLUSIONS: Novel PAD therapy is safe and improves dysphagia symptoms. Biomechanical swallowing changes are suggestive of more efficacious bolus propulsion with conservative filler volume, but this was unable to resolve residue or aspiration measures.
引用
- Schar MS, Omari TI, Woods CM, et al. Pharyngeal tongue base augmentation for dysphagia therapy: A prospective case series in patients post head and neck cancer treatment. Head Neck. 2022. PMID: 35665556. doi:10.1002/hed.27104
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。